TURNOVER (x1000 DKK)
NET PROFIT (x1000 DKK)
EMPLOYEES
Fujirebio Diagnostics AB
Closing information (x1000 DKK)
Closing information | 2024/03 (consolidated) | 2023/03 (consolidated) | 2022/03 (consolidated) |
Turnover |
207,841
|
205,365
|
190,748 |
Financial expenses |
2,805
|
55
|
341 |
Earnings before taxes |
108,564
|
117,202
|
100,270 |
EBITDA |
112,135
|
121,469
|
104,129 |
Total assets |
501,305
|
425,812
|
442,652 |
Current assets |
308,168
|
221,630
|
213,662 |
Current liabilities |
78,597
|
32,897
|
45,726 |
Equity capital |
417,396
|
387,859
|
392,117 |
- share capital |
415
|
423
|
461 |
Employees (average) |
89
|
86
|
75 |
Financial ratios
Fiscal year | 2024/03 (consolidated) | 2023/03 (consolidated) | 2022/03 (consolidated) |
Solvency |
83.3%
|
91.1%
|
88.6% |
Turnover per employee |
2,335
|
2,388
|
2,543 |
Profit as a percentage of turnover |
52.2%
|
57.1%
|
52.6% |
Return on assets (ROA) |
22.2%
|
27.5%
|
22.7% |
Current ratio |
392.1%
|
673.7%
|
467.3% |
Return on equity (ROE) |
26.0%
|
30.2%
|
25.6% |
Change turnover |
6,665
|
30,221
|
10,728 |
Change turnover % |
3%
|
17%
|
6% |
Chg. No. of employees |
3
|
11
|
4 |
Chg. No. of employees % |
3%
|
15%
|
6% |
Total value of public sale
Fiscal year | 2024/03 (consolidated) | 2023/03 (consolidated) | 2022/03 (consolidated) |
Total value of public sale |
0
![]() |
0
![]() |
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.